Maohua Huang

1.3k total citations
33 papers, 668 citations indexed

About

Maohua Huang is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Maohua Huang has authored 33 papers receiving a total of 668 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 10 papers in Cancer Research and 7 papers in Oncology. Recurrent topics in Maohua Huang's work include Peptidase Inhibition and Analysis (4 papers), Phagocytosis and Immune Regulation (4 papers) and Angiogenesis and VEGF in Cancer (3 papers). Maohua Huang is often cited by papers focused on Peptidase Inhibition and Analysis (4 papers), Phagocytosis and Immune Regulation (4 papers) and Angiogenesis and VEGF in Cancer (3 papers). Maohua Huang collaborates with scholars based in China, United States and Taiwan. Maohua Huang's co-authors include Dongmei Zhang, Wen‐Cai Ye, Minfeng Chen, Lijuan Deng, Xueping Lei, Zhe‐Sheng Chen, Chenran Wang, Yehuda G. Assaraf, Dong Zhang and Yinghui Peng and has published in prestigious journals such as PLoS ONE, ACS Applied Materials & Interfaces and International Journal of Molecular Sciences.

In The Last Decade

Maohua Huang

32 papers receiving 663 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maohua Huang China 17 364 162 144 112 55 33 668
Zhe Lin China 16 366 1.0× 132 0.8× 108 0.8× 120 1.1× 37 0.7× 45 829
Chiara Vidoni Italy 19 497 1.4× 211 1.3× 104 0.7× 71 0.6× 35 0.6× 28 944
Sae-Won Lee South Korea 15 457 1.3× 110 0.7× 99 0.7× 81 0.7× 27 0.5× 20 858
Junrong Zou China 16 461 1.3× 196 1.2× 122 0.8× 73 0.7× 94 1.7× 53 769
Qi Huang China 16 287 0.8× 100 0.6× 124 0.9× 67 0.6× 53 1.0× 47 572
Wenjing Lai China 13 296 0.8× 80 0.5× 75 0.5× 144 1.3× 57 1.0× 36 583
Liangliang Shen China 17 466 1.3× 125 0.8× 127 0.9× 79 0.7× 37 0.7× 49 781
Emilly S. Villodre United States 14 494 1.4× 138 0.9× 158 1.1× 65 0.6× 82 1.5× 22 853
Yu‐Chang Liu Taiwan 20 421 1.2× 160 1.0× 177 1.2× 88 0.8× 87 1.6× 34 748

Countries citing papers authored by Maohua Huang

Since Specialization
Citations

This map shows the geographic impact of Maohua Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maohua Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maohua Huang more than expected).

Fields of papers citing papers by Maohua Huang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maohua Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maohua Huang. The network helps show where Maohua Huang may publish in the future.

Co-authorship network of co-authors of Maohua Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Maohua Huang. A scholar is included among the top collaborators of Maohua Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maohua Huang. Maohua Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Chenran, Lin Tan, Maohua Huang, et al.. (2025). Cancer ENO2 Induces Histone Lactylation-Mediated M2 Macrophage Polarization and Facilitates Metastasis of Head and Neck Squamous Cell Carcinoma. Engineering. 48. 262–276. 1 indexed citations
2.
3.
Wang, Sheng, Maohua Huang, Minfeng Chen, et al.. (2023). Zoledronic acid and thymosin α1 elicit antitumor immunity against prostate cancer by enhancing tumor inflammation and cytotoxic T cells. Journal for ImmunoTherapy of Cancer. 11(6). e006381–e006381. 13 indexed citations
4.
Liao, Chun‐De, Hung‐Chou Chen, Maohua Huang, et al.. (2023). Comparative Efficacy of Intra-Articular Injection, Physical Therapy, and Combined Treatments on Pain, Function, and Sarcopenia Indices in Knee Osteoarthritis: A Network Meta-Analysis of Randomized Controlled Trials. International Journal of Molecular Sciences. 24(7). 6078–6078. 18 indexed citations
5.
Huang, Maohua, et al.. (2023). Noninvasive Strategies for the Treatment of Tiny Liver Cancer: Integrating Photothermal Therapy and Multimodality Imaging EpCAM-Guided Nanoparticles. ACS Applied Materials & Interfaces. 15(18). 21843–21853. 5 indexed citations
6.
Lin, Jiapeng, Maohua Huang, Lei Chen, et al.. (2023). Periplocin inhibits hepatocellular carcinoma progression and reduces the recruitment of MDSCs through AKT/NF-κB pathway. Life Sciences. 324. 121715–121715. 11 indexed citations
7.
Wen, Qing, Maohua Huang, Jingwen Xie, et al.. (2023). lncRNA SYTL5-OT4 promotes vessel co-option by inhibiting the autophagic degradation of ASCT2. Drug Resistance Updates. 69. 100975–100975. 9 indexed citations
8.
9.
Jiao, Yubo, Lijuan Deng, Sheng Wang, et al.. (2023). Beauvericin suppresses the proliferation and pulmonary metastasis of osteosarcoma by selectively inhibiting TGFBR2 pathway. International Journal of Biological Sciences. 19(14). 4376–4392. 8 indexed citations
10.
Huang, Maohua, Chenran Wang, Lijuan Deng, et al.. (2022). New insights into antiangiogenic therapy resistance in cancer: Mechanisms and therapeutic aspects. Drug Resistance Updates. 64. 100849–100849. 101 indexed citations
11.
Li, Zheng‐Xiang, Minfeng Chen, Jun Tang, et al.. (2021). Targeting FAPα-expressing tumor-associated mesenchymal stromal cells inhibits triple-negative breast cancer pulmonary metastasis. Cancer Letters. 503. 32–42. 19 indexed citations
12.
Li, Yong, Maohua Huang, Songtao Li, et al.. (2021). 3′-Oxo-tabernaelegantine A (OTNA) selectively relaxes pulmonary arteries by inhibiting AhR. Phytomedicine. 92. 153751–153751. 7 indexed citations
13.
Zhang, Jiayan, Mingqun Liu, Maohua Huang, et al.. (2019). Ginsenoside F1 promotes angiogenesis by activating the IGF-1/IGF1R pathway. Pharmacological Research. 144. 292–305. 82 indexed citations
14.
Chen, Minfeng, Maohua Huang, Jincheng Zhong, et al.. (2019). Targeting platelet-derived growth factor receptor β inhibits the proliferation and motility of human pterygial fibroblasts. Expert Opinion on Therapeutic Targets. 23(9). 805–817. 6 indexed citations
15.
Lei, Xueping, Minfeng Chen, Xiaobo Li, et al.. (2018). A vascular disrupting agent overcomes tumor multidrug resistance by skewing macrophage polarity toward the M1 phenotype. Cancer Letters. 418. 239–249. 16 indexed citations
16.
Chen, Liping, Minfeng Chen, Jianyang Hu, et al.. (2017). Arenobufagin inhibits prostate cancer epithelial-mesenchymal transition and metastasis by down-regulating β-catenin. Pharmacological Research. 123. 130–142. 59 indexed citations
17.
Lei, Xueping, Minfeng Chen, Maohua Huang, et al.. (2017). Desacetylvinblastine Monohydrazide Disrupts Tumor Vessels by Promoting VE-cadherin Internalization. Theranostics. 8(2). 384–398. 19 indexed citations
18.
Lei, Xueping, Minfeng Chen, Jianyang Hu, et al.. (2016). In vitro and in vivo antiangiogenic activity of desacetylvinblastine monohydrazide through inhibition of VEGFR2 and Axl pathways.. PubMed. 6(4). 843–58. 20 indexed citations
19.
Zhang, Chun‐Dong, Fangfang Li, Xiangyun Chen, et al.. (2012). DNA replication events during larval silk gland development in the silkworm, Bombyx mori. Journal of Insect Physiology. 58(7). 974–978. 24 indexed citations
20.
Pan, Min‐Hui, Juan Du, Maohua Huang, et al.. (2011). Cloning of the Flap Endonuclease-1 Gene in Bombyx mori and Identification of an Antiapoptotic Function. DNA and Cell Biology. 30(10). 763–770. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhe Lin Breakdown of academic impact, for papers by Chiara Vidoni Breakdown of academic impact, for papers by Sae-Won Lee Breakdown of academic impact, for papers by Junrong Zou Breakdown of academic impact, for papers by Qi Huang Breakdown of academic impact, for papers by Wenjing Lai Breakdown of academic impact, for papers by Liangliang Shen Breakdown of academic impact, for papers by Emilly S. Villodre Breakdown of academic impact, for papers by Yu‐Chang Liu
Rankless by CCL
2026